Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Transfusion risks and alternatives to transfusion].

G de Stasio1

  • 1Servizio di Immunoematologia e trasfusione, Ospedale Di Venere, Bari-Carbonara.

Recenti Progressi in Medicina
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy.

Cancer research·2001
Same author

Formation of sphalerite (ZnS) deposits in natural biofilms of sulfate-reducing bacteria.

Science (New York, N.Y.)·2000
Same author

Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000
Same author

Charging phenomena in PEEM imaging and spectroscopy.

Ultramicroscopy·2000
Same author

UV-ozone ashing of cells and tissues for spatially resolved trace element analysis.

Frontiers in bioscience : a journal and virtual library·2000
Same author

Cell ashing for trace element analysis: A new approach based on ultraviolet/ozone.

Analytical biochemistry·1999

Blood transfusions are safer due to improved screening, but risks like hepatitis and ABO incompatibility remain. While rare, adverse reactions and immune suppression are potential concerns for transfusion recipients.

Area of Science:

  • Transfusion Medicine
  • Immunology
  • Infectious Diseases

Background:

  • Concerns regarding blood transfusion safety, particularly related to Acquired Immunodeficiency Syndrome (AIDS), have been significant.
  • Despite fears, the risk of AIDS transmission via transfusion is now very low (1 in 60,000 units).
  • Enhanced donor screening and testing have made the blood supply safer than ever before.

Purpose of the Study:

  • To evaluate the current risks and adverse effects associated with homologous blood transfusions.
  • To inform physicians and patients about the safety profile of blood transfusions.
  • To highlight the decreasing, yet persistent, risks of infectious disease transmission and other complications.

Main Methods:

  • Review of current data on transfusion-associated risks.

Related Experiment Videos

  • Analysis of infectious disease transmission rates.
  • Assessment of non-infectious adverse events and immune modulation.

    • Main Results:

    • The risk of transmitting infectious diseases through blood transfusions is decreasing.
    • Common transfusion reactions include fever and rash (1-3%).
    • Serious risks include ABO incompatibility (fatal hemolytic reactions 1 in 100,000-400,000), hepatitis C (1-3% of recipients), Cytomegalovirus, and bacterial/protozoal infections.
    • Homologous transfusions can suppress immune function, potentially compromising defenses against infection and malignancy.

    Conclusions:

    • While the blood supply is safer, small transfusion risks persist.
    • Hepatitis C and ABO incompatibility remain significant concerns.
    • Transfusion-associated immune suppression warrants consideration, especially in vulnerable patients.